Compare Novavax Inc (NVAX) vs Trip.com Group Ltd (TCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Trip.com Group Ltd — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Trip.com Group Ltd trades at $43.78 (market cap $28.12B). The key difference: Trip.com Group Ltd is far larger — about 21.6× Novavax Inc's market cap, and Trip.com Group Ltd pays a 0.42% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | TCOM | |
|---|---|---|
Market Cap | $1.30B | $28.12B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $78.96 |
52-Week Low | $6.22 | $39.84 |
Enterprise Value | $800.50M | $20.82B |
Dividend Yield | — | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →
